Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 16 of 1,261
  1. US 12403141

    Deuterated MK2 pathway inhibitors and methods of using the same

    Aclaris Therapeutics, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  2. US 12403164

    Lentiviral vector formulations

    BIOVERATIV THERAPEUTICS INC. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  3. US 12403183

    Factor VIII polypeptide formulations

    BIOVERATIV THERAPEUTICS INC. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  4. US 12403203

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  5. US 12404243

    Inhibitors of the Wnt/beta-catenin pathway

    The Regents of the University of California · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  6. US 12404317

    T cell receptors recognizing MHC class II-restricted MAGE-A3

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  7. US 12404318

    Combination HBV therapy

    Vir Biotechnology, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  8. US 12404335

    Compositions and methods for treatment of thyroid eye disease

    Viridian Therapeutics, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  9. US 12404313

    GDNF fusion polypeptides and methods of use thereof

    Keros Therapeutics, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  10. US 12404347

    Glucuronoxylomannan (GXM) receptor chimeric antigen receptors and use thereof

    The Board of Regents of the University of Texas System · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  11. US 12404533

    Bioconjugate vaccines' synthesis in prokaryotic cell lysates

    Northwestern University · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  12. US 12404505

    Delivery of a gene-editing system with a single retroviral particle and methods of generation and use

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  13. US 12403154

    Administration of sting agonist and checkpoint inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  14. US 12403137

    Compounds and methods of use

    Tango Therapeutics, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  15. US 12404508

    Ketohexokinase (KHK) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  16. US 12403192

    Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  17. US 12403134

    Method for improving or enhancing cognition

    VANDA PHARMACEUTICALS INC. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  18. US 12404275

    Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereof

    PrimeGene (Beijing) Co., Ltd. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  19. US 12403167

    Phenylethanoid glycoside extract from Acanthus ilicifolius L., preparation method thereof and use as anti-liver injury medicament

    OCEAN UNIVERSITY OF CHINA · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  20. US 12403136

    Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  21. US 12403069

    Adapter for use in a planetary mixer

    MEDISCA PHARMACEUTIQUE INC. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  22. US 12403200

    Methods and compositions for treating autoimmune diseases

    Vor Biopharma Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  23. US 12403196

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  24. US 12404297

    Salts and crystal forms of GABA-A positive allosteric modulator

    PRAXIS PRECISION MEDICINES, INC. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.